Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Neuropharmacology|October 1, 1995
Levodopa does not aggravate postural tremor in Parkinson's diseaseJ Kulisevsky, A Avila, M Barbanoj, et al.
Neuropsychobiology|September 20, 2007
Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteersM J Barbanoj, G Urbano, R Antonijoan, et al.
Thrombosis Research|April 1, 1995
Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteersL Falkon, D Sáenz-Campos, R Antonijoan, et al.
Brain : a Journal of Neurology|December 1, 1996
Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levelsJ Kulisevsky, A Avila, M Barbanoj, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 6, 2005
Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availabilityM-J Barbanoj, R Antonijoan, C García-Gea, et al.
Psychopharmacology|October 18, 2001
Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response studyJ Riba, A Rodríguez-Fornells, G Urbano, et al.
Psychopharmacology|April 9, 2001
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteersJ Riba, A Rodríguez-Fornells, G Urbano, et al.
Nuclear Medicine Communications|May 27, 2003
Evaluation of renal graft haemodynamia by 51Cr-EDTA and o-[131I]iodohippurate: its use in the early diagnosis of glomerular hyperfiltrationM Estorch, A Tembl, R Antonijoan, et al.
Clinical Pharmacology and Therapeutics|December 1, 1999
Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiencyM Barbanoj, R Antonijoan, A Morte, et al.
Pageof 1